From these studies it can be concluded that Ca2+ entry through TRPC6 and TRPV4 contributes to the growth and progression of HCC, while activation of TRPV1 may be targeted to kill HCC cells. The gene discussed is TRPC6; the disease is hepatocellular carcinoma.